Boxer Capital’s Medicines Co MDCO Stock Holding History

Boxer Capital’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-100,000	Closed	-$8.49M	–	69
2019 Q4	$8.49M	Buy	+100,000	New	+$6.67M	0.48%	40
2017 Q3	–	Sell	-530,600	Closed	-$20.2M	–	33
2017 Q2	$20.2M	Sell	530,600 -153,100	-22%	-$6.82M	4.8%	8
2017 Q1	$33.4M	Buy	683,700 +56,300	+9%	+$2.57M	7.31%	5
2016 Q4	$21.3M	Buy	627,400 +77,600	+14%	+$2.75M	8.24%	5
2016 Q3	$20.7M	Buy	+549,800	New	+$20.7M	9.3%	4

Other funds holding MDCO

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Boxer Capital's MDCO Position: Q1 2020 in Review

Boxer Capital sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 967,000 shares — an estimated $82.1M sold.

Boxer Capital first reported a position in MDCO in Q3 2016 and held it in 14 quarters. The position peaked at $82.1M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

Boxer Capital reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
Boxer Capital sold 967,000 Medicines Co shares in Q1 2020, an estimated $82.1M.
Boxer Capital first reported a position in Medicines Co in Q3 2016 and held it in 14 quarters.
Boxer Capital's Medicines Co position peaked at $82.1M in Q4 2019.
1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Boxer Capital's 13F filing for Q1 2020, filed 15 May 2020.